Choate's Life Sciences Insights
8 episodes - English - Latest episode: 11 months ago - ★★★★★ - 1 ratingA podcast series hosted by our intellectual property, litigation, and corporate attorneys covering trending topics at the intersection of science and law.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
A Debrief of the Supreme Court’s Decision in Amgen v. Sanofi
June 12, 2023 04:00 - 20 minutes - 1.22 KBIn this episode of Choate’s Life Sciences Insights Podcast Series, Sophie Wang, Stephanie Schonewald and Peter Flynn discuss the US Supreme Court’s opinion in Amgen v. Sanofi, one of this term’s most highly-watched cases for our clients concerning the law of enablement as it applies to patents directed to antibody therapeutics.
PTAB Podcast: Recent USPTO Update on Fintiv Factors and Discretionary Denials
July 11, 2022 04:00 - 18 minutes - 1.08 KBSteph Schonewald, Sophie Wang and Emily Miller discuss the recent memo issued by USPTO Director Vidal concerning the Fintiv factors and discretionary denials in AIA post-grant proceedings.
Conducting Clinical Trials Part 5: Confidentiality Issues
December 06, 2021 05:00 - 19 minutes - 1.14 KBIn the fifth and final installment of Choate’s Conducting Clinical Trials series, Julia Hesse and Danielle Pelot analyze confidentiality issues that can arise with clinical trial information and provide cautionary takeaways for when sponsors (life sciences companies) are planning and working with sites in structuring trials.
Conducting Clinical Trials Part 4: Financial Conflicts of Interest
November 08, 2021 05:00 - 13 minutes - 813 BytesIn the fourth installment of Choate’s Conducting Clinical Trials series, Mark McPherson and Greta Fails cover what financial conflicts of interest are in a clinical trials context, how federal funding agencies regulate them, and enforcement trends.
Conducting Clinical Trials Part 3: Common Mistakes in Press Releases
October 18, 2021 04:00 - 9 minutes - 565 BytesIn the third installment of Choate’s Conducting Clinical Trials series, Diana Lloyd and Melissa Tearney discuss common mistakes made in clinical trial related press releases and how companies can avoid unnecessary government investigations and disastrous consequences caused by problematic press releases.
Conducting Clinical Trials Part 2: Avoiding Mistaken Public Disclosures
September 30, 2021 04:00 - 11 minutes - 699 BytesIn the second installment of Choate’s Conducting Clinical Trials series, Christine Savage and Eric Marandett cover issues that can arise when there is premature or mistaken public disclosure of sensitive clinical trial information and discuss strategies companies can use to minimize the likelihood of encountering issues from inadvertently releasing information.
Conducting Clinical Trials Part 1: When Should You File Your Patent Applications?
September 13, 2021 04:00 - 14 minutes - 896 BytesAs the first installment of Choate’s Conducting Clinical Trials series, Bryana McGillycuddy and John Rearick discuss a range of implications associated with the timing of filing, including the validity of the patent and the risk of inadvertent disclosure.
Does the Amgen Case Raise the Bar for Enablement?
May 17, 2021 04:00 - 10 minutes - 625 BytesEric Marandett and Rolando Medina review Amgen v. Sanofi and discuss strategies for how to successfully describe, claim, and assert antibody patents in the evolving legal landscape.